The US alone has almost 10 million horses.
The most current estimates are that 10% to 15% of horses will suffer from laminitis every year, with 80% to 90% of the cases caused by endocrine disease. On average, that is 1 million horses per year in the US alone.
By focusing on prevention and treatment of endocrinopathic laminitis, the ECIR Group has assisted thousands of horses and their caregivers in understanding the importance of diagnosis, diet, trim, and exercise to improve the welfare of equines with metabolic disorder.
Attendees of the four previous conferences welcomed the latest in research and specific protocols used to improve the welfare of equines in their care. The 2021 NO Laminitis! Virtual Conference will continue to build on that mission, and will also be a special celebration of the 21 years that the ECIR Group has remained dedicated to the quest of helping metabolic equines.
NO Laminitis! Conference
The 2021 NO Laminitis! Conference continues the mission to serve the scientific community, practicing clinicians, and owners by focusing on investigations most likely to quickly, immediately, and significantly benefit the welfare of the horse.
When: The weekend of August 13 - 15, 2021
Where: ECIR Group Virtual Conference Room via Zoom
Attendees: Any professional or owner who has one or more horses in their care.
Missed the 2021 conference?
Subscribe to view all the videos.Subscribe Here
Robert M. Bowker, VMD, PhD
Kathleen Gustafson, PhD
Eleanor M. Kellon, VMD
Elaine Norton, DVM, MS, PhD, DACVIM-LA
Paige Poss, APF - Anatomy of the Equine, LLC
Shannon Pratt-Phillips, MS, PhD, PAS
Pete Ramey, PHCP Practitioner/Clinician
- EMS – What It's Not.
- Protein and Iron — Their Affect in EMS and PPID Horses.
- Pros and Cons of Forage Analysis and Targeted Supplementation.
- The Effect of Exercise on Glucose Metabolism and Insulin Sensitivity in the Horse.
- Strategies for Using Exercise as Part of Dietary Management for Overweight and/or Insulin Resistant Horses.
- Common EMS and PPID Pharmaceuticals.
- Emerging EMS and PPID Pharmaceuticals.
- The Genetics of EMS.
- The Impact of Genetics on Height and Insulin Dysregulation in Welsh Ponies.
- Take it with a Grain of Salt – Navigating Nutritional Fact and Fiction.
- Reading the Foot – Thinking Vertically.
- Reversing Hoof Capsule Rotation and Distal Descent.
- Looking Internally at Distal Descent and Rotation in the Hoof.
- Estimating Palmar Angle when Looking at the Hoof.
- What is a Normal Foot? Questions Need to be Asked.
- Trimming Practices Can Encourage Decline in Overall Foot Health.
- Winter Laminitis: Why the normal trim can make an episode worse.
- How Trimming Can Improve Foot Structure and Function.
View Full Conference Schedule
Click here for more information about Continuing Education Credit.
About the ECIR Group
Started in 1999, the ECIR Group is the largest field-trial database for Pituitary Pars Intermedia Dysfunction (PPID) and Equine Metabolic Syndrome (EMS)/Insulin Resistance (IR) in the world, and provides the latest research, diagnosis, and treatment information, including dietary recommendations, for horses with these conditions. The approach to help maintain optimum equine health is the Diagnosis, Diet, Trim and Exercise (DDT/E) Protocol.